Crossref
What are the benefits and risks of aspirin for the primary prevention of colorectal cancer and colorectal adenoma?
Cochrane Clinical Answers · 27.04.2026
DOI: 10.1002/cca.4789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cochrane Clinical Answers, online erschienen am 27.04.2026. Verfasst von Amin Sharifan. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sharifan, A. (2026). What are the benefits and risks of aspirin for the primary prevention of colorectal cancer and colorectal adenoma?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.4789
Vancouver
Sharifan A. What are the benefits and risks of aspirin for the primary prevention of colorectal cancer and colorectal adenoma?. Cochrane Clinical Answers. 2026. doi:10.1002/cca.4789
BibTeX
@article{Sharifan2026,
author = {Sharifan, Amin},
title = {What are the benefits and risks of aspirin for the primary prevention of colorectal cancer and colorectal adenoma?},
journal = {Cochrane Clinical Answers},
year = {2026},
doi = {10.1002/cca.4789}
}
EUVIMED